ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autoimmune Hepatitis Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-5E1203
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autoimmune Hepatitis Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Autoimmune Hepatitis Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-5E1203
Report
December 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences Inc
Acorda Therapeutics Inc
Allergan & Novartis
Intercept Pharmaceuticals Inc
Hightidetx
Shire Plc
NGM Biopharmaceuticals, Inc.
EA Pharma
BiomX
CymaBay Therapeutics
Conatus Pharmaceuticals Inc
DURECT Corporation
Sirnaomics
Shenzhen HighTide Biopharmaceuticals Ltd.

Autoimmune Hepatitis Treatment Market

Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body's own immune system attacks the liver and causes it to become inflamed.
Market Analysis and Insights: Global Autoimmune Hepatitis Treatment Market
The global Autoimmune Hepatitis Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Autoimmune Hepatitis Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Autoimmune Hepatitis Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Autoimmune Hepatitis Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Autoimmune Hepatitis Treatment include Gilead Sciences, Inc., Acorda Therapeutics, Inc., Allergan & Novartis, Intercept Pharmaceuticals, Inc., Hightidetx, Shire Plc., NGM Biopharmaceuticals, Inc., EA Pharma and BiomX, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Autoimmune Hepatitis Treatment is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Autoimmune Hepatitis Treatment industry development. In 2023, global % revenue of Autoimmune Hepatitis Treatment went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Autoimmune Hepatitis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Autoimmune Hepatitis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Autoimmune Hepatitis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Autoimmune Hepatitis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Autoimmune Hepatitis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Autoimmune Hepatitis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Autoimmune Hepatitis Treatment Market Report

Report Metric Details
Report Name Autoimmune Hepatitis Treatment Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, Inc., Acorda Therapeutics, Inc., Allergan & Novartis, Intercept Pharmaceuticals, Inc., Hightidetx, Shire Plc., NGM Biopharmaceuticals, Inc., EA Pharma, BiomX, CymaBay Therapeutics, Conatus Pharmaceuticals, Inc., Durect Corporation, Sirnaomics, Inc., Shenzhen HighTide Biopharmaceuticals Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Autoimmune Hepatitis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Autoimmune Hepatitis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autoimmune Hepatitis Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Autoimmune Hepatitis Treatment Market report?

Ans: The main players in the Autoimmune Hepatitis Treatment Market are Gilead Sciences, Inc., Acorda Therapeutics, Inc., Allergan & Novartis, Intercept Pharmaceuticals, Inc., Hightidetx, Shire Plc., NGM Biopharmaceuticals, Inc., EA Pharma, BiomX, CymaBay Therapeutics, Conatus Pharmaceuticals, Inc., Durect Corporation, Sirnaomics, Inc., Shenzhen HighTide Biopharmaceuticals Ltd.

What are the Application segmentation covered in the Autoimmune Hepatitis Treatment Market report?

Ans: The Applications covered in the Autoimmune Hepatitis Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Autoimmune Hepatitis Treatment Market report?

Ans: The Types covered in the Autoimmune Hepatitis Treatment Market report are Table Product, Inject Product, Others

Recommended Reports

Liver Diseases

Liver Cancer Diagnostics

Autoimmune & Other Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Table Product
1.2.3 Inject Product
1.2.4 Others
1.3 Market by Application
1.3.1 Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Hepatitis Treatment Market Perspective (2019-2030)
2.2 Global Autoimmune Hepatitis Treatment Growth Trends by Region
2.2.1 Autoimmune Hepatitis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autoimmune Hepatitis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Autoimmune Hepatitis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Autoimmune Hepatitis Treatment Market Dynamics
2.3.1 Autoimmune Hepatitis Treatment Industry Trends
2.3.2 Autoimmune Hepatitis Treatment Market Drivers
2.3.3 Autoimmune Hepatitis Treatment Market Challenges
2.3.4 Autoimmune Hepatitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Autoimmune Hepatitis Treatment by Players
3.1.1 Global Autoimmune Hepatitis Treatment Revenue by Players (2019-2024)
3.1.2 Global Autoimmune Hepatitis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Autoimmune Hepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Autoimmune Hepatitis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Autoimmune Hepatitis Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Hepatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Hepatitis Treatment Revenue in 2023
3.5 Global Key Players of Autoimmune Hepatitis Treatment Head office and Area Served
3.6 Global Key Players of Autoimmune Hepatitis Treatment, Product and Application
3.7 Global Key Players of Autoimmune Hepatitis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Hepatitis Treatment Breakdown Data by Type
4.1 Global Autoimmune Hepatitis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Autoimmune Hepatitis Treatment Forecasted Market Size by Type (2025-2030)
5 Autoimmune Hepatitis Treatment Breakdown Data by Application
5.1 Global Autoimmune Hepatitis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Autoimmune Hepatitis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autoimmune Hepatitis Treatment Market Size (2019-2030)
6.2 North America Autoimmune Hepatitis Treatment Market Size by Type
6.2.1 North America Autoimmune Hepatitis Treatment Market Size by Type (2019-2024)
6.2.2 North America Autoimmune Hepatitis Treatment Market Size by Type (2025-2030)
6.2.3 North America Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
6.3 North America Autoimmune Hepatitis Treatment Market Size by Application
6.3.1 North America Autoimmune Hepatitis Treatment Market Size by Application (2019-2024)
6.3.2 North America Autoimmune Hepatitis Treatment Market Size by Application (2025-2030)
6.3.3 North America Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
6.4 North America Autoimmune Hepatitis Treatment Market Size by Country
6.4.1 North America Autoimmune Hepatitis Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Autoimmune Hepatitis Treatment Market Size by Country (2019-2024)
6.4.3 North America Autoimmune Hepatitis Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Autoimmune Hepatitis Treatment Market Size (2019-2030)
7.2 Europe Autoimmune Hepatitis Treatment Market Size by Type
7.2.1 Europe Autoimmune Hepatitis Treatment Market Size by Type (2019-2024)
7.2.2 Europe Autoimmune Hepatitis Treatment Market Size by Type (2025-2030)
7.2.3 Europe Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
7.3 Europe Autoimmune Hepatitis Treatment Market Size by Application
7.3.1 Europe Autoimmune Hepatitis Treatment Market Size by Application (2019-2024)
7.3.2 Europe Autoimmune Hepatitis Treatment Market Size by Application (2025-2030)
7.3.3 Europe Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
7.4 Europe Autoimmune Hepatitis Treatment Market Size by Country
7.4.1 Europe Autoimmune Hepatitis Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Autoimmune Hepatitis Treatment Market Size by Country (2019-2024)
7.4.3 Europe Autoimmune Hepatitis Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Autoimmune Hepatitis Treatment Market Size (2019-2030)
8.2 China Autoimmune Hepatitis Treatment Market Size by Type
8.2.1 China Autoimmune Hepatitis Treatment Market Size by Type (2019-2024)
8.2.2 China Autoimmune Hepatitis Treatment Market Size by Type (2025-2030)
8.2.3 China Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
8.3 China Autoimmune Hepatitis Treatment Market Size by Application
8.3.1 China Autoimmune Hepatitis Treatment Market Size by Application (2019-2024)
8.3.2 China Autoimmune Hepatitis Treatment Market Size by Application (2025-2030)
8.3.3 China Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Autoimmune Hepatitis Treatment Market Size (2019-2030)
9.2 Asia Autoimmune Hepatitis Treatment Market Size by Type
9.2.1 Asia Autoimmune Hepatitis Treatment Market Size by Type (2019-2024)
9.2.2 Asia Autoimmune Hepatitis Treatment Market Size by Type (2025-2030)
9.2.3 Asia Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
9.3 Asia Autoimmune Hepatitis Treatment Market Size by Application
9.3.1 Asia Autoimmune Hepatitis Treatment Market Size by Application (2019-2024)
9.3.2 Asia Autoimmune Hepatitis Treatment Market Size by Application (2025-2030)
9.3.3 Asia Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
9.4 Asia Autoimmune Hepatitis Treatment Market Size by Region
9.4.1 Asia Autoimmune Hepatitis Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Autoimmune Hepatitis Treatment Market Size by Region (2019-2024)
9.4.3 Asia Autoimmune Hepatitis Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Introduction
11.1.4 Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.1.5 Gilead Sciences, Inc. Recent Developments
11.2 Acorda Therapeutics, Inc.
11.2.1 Acorda Therapeutics, Inc. Company Details
11.2.2 Acorda Therapeutics, Inc. Business Overview
11.2.3 Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Introduction
11.2.4 Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.2.5 Acorda Therapeutics, Inc. Recent Developments
11.3 Allergan & Novartis
11.3.1 Allergan & Novartis Company Details
11.3.2 Allergan & Novartis Business Overview
11.3.3 Allergan & Novartis Autoimmune Hepatitis Treatment Introduction
11.3.4 Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.3.5 Allergan & Novartis Recent Developments
11.4 Intercept Pharmaceuticals, Inc.
11.4.1 Intercept Pharmaceuticals, Inc. Company Details
11.4.2 Intercept Pharmaceuticals, Inc. Business Overview
11.4.3 Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
11.4.4 Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.4.5 Intercept Pharmaceuticals, Inc. Recent Developments
11.5 Hightidetx
11.5.1 Hightidetx Company Details
11.5.2 Hightidetx Business Overview
11.5.3 Hightidetx Autoimmune Hepatitis Treatment Introduction
11.5.4 Hightidetx Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.5.5 Hightidetx Recent Developments
11.6 Shire Plc.
11.6.1 Shire Plc. Company Details
11.6.2 Shire Plc. Business Overview
11.6.3 Shire Plc. Autoimmune Hepatitis Treatment Introduction
11.6.4 Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.6.5 Shire Plc. Recent Developments
11.7 NGM Biopharmaceuticals, Inc.
11.7.1 NGM Biopharmaceuticals, Inc. Company Details
11.7.2 NGM Biopharmaceuticals, Inc. Business Overview
11.7.3 NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
11.7.4 NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.7.5 NGM Biopharmaceuticals, Inc. Recent Developments
11.8 EA Pharma
11.8.1 EA Pharma Company Details
11.8.2 EA Pharma Business Overview
11.8.3 EA Pharma Autoimmune Hepatitis Treatment Introduction
11.8.4 EA Pharma Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.8.5 EA Pharma Recent Developments
11.9 BiomX
11.9.1 BiomX Company Details
11.9.2 BiomX Business Overview
11.9.3 BiomX Autoimmune Hepatitis Treatment Introduction
11.9.4 BiomX Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.9.5 BiomX Recent Developments
11.10 CymaBay Therapeutics
11.10.1 CymaBay Therapeutics Company Details
11.10.2 CymaBay Therapeutics Business Overview
11.10.3 CymaBay Therapeutics Autoimmune Hepatitis Treatment Introduction
11.10.4 CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.10.5 CymaBay Therapeutics Recent Developments
11.11 Conatus Pharmaceuticals, Inc.
11.11.1 Conatus Pharmaceuticals, Inc. Company Details
11.11.2 Conatus Pharmaceuticals, Inc. Business Overview
11.11.3 Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
11.11.4 Conatus Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.11.5 Conatus Pharmaceuticals, Inc. Recent Developments
11.12 Durect Corporation
11.12.1 Durect Corporation Company Details
11.12.2 Durect Corporation Business Overview
11.12.3 Durect Corporation Autoimmune Hepatitis Treatment Introduction
11.12.4 Durect Corporation Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.12.5 Durect Corporation Recent Developments
11.13 Sirnaomics, Inc.
11.13.1 Sirnaomics, Inc. Company Details
11.13.2 Sirnaomics, Inc. Business Overview
11.13.3 Sirnaomics, Inc. Autoimmune Hepatitis Treatment Introduction
11.13.4 Sirnaomics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.13.5 Sirnaomics, Inc. Recent Developments
11.14 Shenzhen HighTide Biopharmaceuticals Ltd.
11.14.1 Shenzhen HighTide Biopharmaceuticals Ltd. Company Details
11.14.2 Shenzhen HighTide Biopharmaceuticals Ltd. Business Overview
11.14.3 Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Introduction
11.14.4 Shenzhen HighTide Biopharmaceuticals Ltd. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024)
11.14.5 Shenzhen HighTide Biopharmaceuticals Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Gilead Sciences Inc
Acorda Therapeutics Inc
Allergan & Novartis
Intercept Pharmaceuticals Inc
Hightidetx
Shire Plc
NGM Biopharmaceuticals, Inc.
EA Pharma
BiomX
CymaBay Therapeutics
Conatus Pharmaceuticals Inc
DURECT Corporation
Sirnaomics
Shenzhen HighTide Biopharmaceuticals Ltd.
List of Tables
    Table 1. Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Table Product
    Table 3. Key Players of Inject Product
    Table 4. Key Players of Others
    Table 5. Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Autoimmune Hepatitis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Autoimmune Hepatitis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Autoimmune Hepatitis Treatment Market Share by Region (2019-2024)
    Table 9. Global Autoimmune Hepatitis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Autoimmune Hepatitis Treatment Market Share by Region (2025-2030)
    Table 11. Autoimmune Hepatitis Treatment Market Trends
    Table 12. Autoimmune Hepatitis Treatment Market Drivers
    Table 13. Autoimmune Hepatitis Treatment Market Challenges
    Table 14. Autoimmune Hepatitis Treatment Market Restraints
    Table 15. Global Autoimmune Hepatitis Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Autoimmune Hepatitis Treatment Revenue Share by Players (2019-2024)
    Table 17. Global Top Autoimmune Hepatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Hepatitis Treatment as of 2023)
    Table 18. Global Autoimmune Hepatitis Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Autoimmune Hepatitis Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Autoimmune Hepatitis Treatment, Headquarters and Area Served
    Table 21. Global Key Players of Autoimmune Hepatitis Treatment, Product and Application
    Table 22. Global Key Players of Autoimmune Hepatitis Treatment, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Autoimmune Hepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Autoimmune Hepatitis Treatment Revenue Market Share by Type (2019-2024)
    Table 26. Global Autoimmune Hepatitis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Autoimmune Hepatitis Treatment Revenue Market Share by Type (2025-2030)
    Table 28. Global Autoimmune Hepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Autoimmune Hepatitis Treatment Revenue Share by Application (2019-2024)
    Table 30. Global Autoimmune Hepatitis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Autoimmune Hepatitis Treatment Revenue Share by Application (2025-2030)
    Table 32. North America Autoimmune Hepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Autoimmune Hepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Autoimmune Hepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Autoimmune Hepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Autoimmune Hepatitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Autoimmune Hepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Autoimmune Hepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Autoimmune Hepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Autoimmune Hepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Autoimmune Hepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Autoimmune Hepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Autoimmune Hepatitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Autoimmune Hepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Autoimmune Hepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Autoimmune Hepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Autoimmune Hepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Autoimmune Hepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Autoimmune Hepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Autoimmune Hepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Autoimmune Hepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Autoimmune Hepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Autoimmune Hepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Autoimmune Hepatitis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Autoimmune Hepatitis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Autoimmune Hepatitis Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Gilead Sciences, Inc. Company Details
    Table 65. Gilead Sciences, Inc. Business Overview
    Table 66. Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Product
    Table 67. Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 68. Gilead Sciences, Inc. Recent Developments
    Table 69. Acorda Therapeutics, Inc. Company Details
    Table 70. Acorda Therapeutics, Inc. Business Overview
    Table 71. Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Product
    Table 72. Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 73. Acorda Therapeutics, Inc. Recent Developments
    Table 74. Allergan & Novartis Company Details
    Table 75. Allergan & Novartis Business Overview
    Table 76. Allergan & Novartis Autoimmune Hepatitis Treatment Product
    Table 77. Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 78. Allergan & Novartis Recent Developments
    Table 79. Intercept Pharmaceuticals, Inc. Company Details
    Table 80. Intercept Pharmaceuticals, Inc. Business Overview
    Table 81. Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product
    Table 82. Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 83. Intercept Pharmaceuticals, Inc. Recent Developments
    Table 84. Hightidetx Company Details
    Table 85. Hightidetx Business Overview
    Table 86. Hightidetx Autoimmune Hepatitis Treatment Product
    Table 87. Hightidetx Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 88. Hightidetx Recent Developments
    Table 89. Shire Plc. Company Details
    Table 90. Shire Plc. Business Overview
    Table 91. Shire Plc. Autoimmune Hepatitis Treatment Product
    Table 92. Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 93. Shire Plc. Recent Developments
    Table 94. NGM Biopharmaceuticals, Inc. Company Details
    Table 95. NGM Biopharmaceuticals, Inc. Business Overview
    Table 96. NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product
    Table 97. NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 98. NGM Biopharmaceuticals, Inc. Recent Developments
    Table 99. EA Pharma Company Details
    Table 100. EA Pharma Business Overview
    Table 101. EA Pharma Autoimmune Hepatitis Treatment Product
    Table 102. EA Pharma Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 103. EA Pharma Recent Developments
    Table 104. BiomX Company Details
    Table 105. BiomX Business Overview
    Table 106. BiomX Autoimmune Hepatitis Treatment Product
    Table 107. BiomX Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 108. BiomX Recent Developments
    Table 109. CymaBay Therapeutics Company Details
    Table 110. CymaBay Therapeutics Business Overview
    Table 111. CymaBay Therapeutics Autoimmune Hepatitis Treatment Product
    Table 112. CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 113. CymaBay Therapeutics Recent Developments
    Table 114. Conatus Pharmaceuticals, Inc. Company Details
    Table 115. Conatus Pharmaceuticals, Inc. Business Overview
    Table 116. Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product
    Table 117. Conatus Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 118. Conatus Pharmaceuticals, Inc. Recent Developments
    Table 119. Durect Corporation Company Details
    Table 120. Durect Corporation Business Overview
    Table 121. Durect Corporation Autoimmune Hepatitis Treatment Product
    Table 122. Durect Corporation Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 123. Durect Corporation Recent Developments
    Table 124. Sirnaomics, Inc. Company Details
    Table 125. Sirnaomics, Inc. Business Overview
    Table 126. Sirnaomics, Inc. Autoimmune Hepatitis Treatment Product
    Table 127. Sirnaomics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 128. Sirnaomics, Inc. Recent Developments
    Table 129. Shenzhen HighTide Biopharmaceuticals Ltd. Company Details
    Table 130. Shenzhen HighTide Biopharmaceuticals Ltd. Business Overview
    Table 131. Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Product
    Table 132. Shenzhen HighTide Biopharmaceuticals Ltd. Revenue in Autoimmune Hepatitis Treatment Business (2019-2024) & (US$ Million)
    Table 133. Shenzhen HighTide Biopharmaceuticals Ltd. Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Autoimmune Hepatitis Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Table Product Features
    Figure 4. Inject Product Features
    Figure 5. Others Features
    Figure 6. Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Autoimmune Hepatitis Treatment Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Autoimmune Hepatitis Treatment Report Years Considered
    Figure 12. Global Autoimmune Hepatitis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Autoimmune Hepatitis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Autoimmune Hepatitis Treatment Market Share by Region: 2023 VS 2030
    Figure 15. Global Autoimmune Hepatitis Treatment Market Share by Players in 2023
    Figure 16. Global Top Autoimmune Hepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Hepatitis Treatment as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Autoimmune Hepatitis Treatment Revenue in 2023
    Figure 18. North America Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
    Figure 20. North America Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
    Figure 21. North America Autoimmune Hepatitis Treatment Market Share by Country (2019-2030)
    Figure 22. United States Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Autoimmune Hepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
    Figure 26. Europe Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
    Figure 27. Europe Autoimmune Hepatitis Treatment Market Share by Country (2019-2030)
    Figure 28. Germany Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Autoimmune Hepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
    Figure 36. China Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
    Figure 37. Asia Autoimmune Hepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
    Figure 39. Asia Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
    Figure 40. Asia Autoimmune Hepatitis Treatment Market Share by Region (2019-2030)
    Figure 41. Japan Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Autoimmune Hepatitis Treatment Market Share by Country (2019-2030)
    Figure 51. Brazil Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Autoimmune Hepatitis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Gilead Sciences, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 58. Acorda Therapeutics, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 59. Allergan & Novartis Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 60. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 61. Hightidetx Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 62. Shire Plc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 63. NGM Biopharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 64. EA Pharma Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 65. BiomX Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 66. CymaBay Therapeutics Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 67. Conatus Pharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 68. Durect Corporation Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 69. Sirnaomics, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 70. Shenzhen HighTide Biopharmaceuticals Ltd. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Autoimmune Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alcoholic Hepatitis Treatment Market Insights Forecast to 2030
Autoimmune Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Cirrhosis Treatment Market Research Report 2025
Global Hepatitis B Treatment Market Insights Forecast to 2030
Global Autoimmune Disease Drugs Market Research Report 2025
Global Autoimmunity Reagents Market Research Report 2024
Global Liver Cirrhosis Market Research Report 2024
Global Cardiac Cirrhosis Treatment Market Research Report 2024
Global Hepatitis C Treatment Drug Market Research Report 2024
Global Primary Biliary Cholangitis Therapeutics Market Insights Forecast to 2030
Non Alcoholic Steatohepatitis Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis B Infectious Disease Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2025
Global Acute Liver Failure Treatment Market Research Report 2025
Alcoholic Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Auto Immune Disease Diagnostics for Animal Market Research Report 2024
Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Hepatitis C Drugs Market Research Report 2024
Global Animal Auto Immune Disease Diagnostics Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions